Founded in 1950 and headquartered in Ravensburg, Germany, Vetter Pharma-Fertigung GmbH & Co. KG is a family-owned contract development and manufacturing organization (CDMO) specializing in aseptic fill-and-finish services for injectable pharmaceuticals. With over 75 years of experience, the company reported annual sales of €1.114 billion in 2024 and employs more than 7,300 people.
Vetter's technical capabilities span the full lifecycle of sterile drug products, from drug product development and process design through to aseptic filling, visual inspection, device assembly, and packaging. Its core product portfolio includes aseptically prefilled syringes, cartridges, vials, and dual-chamber systems manufactured for the global pharmaceutical and biotech industry.
The company operates production sites in Germany, Austria, and the United States, with sales offices in Singapore, Japan, South Korea, and China. As a family-owned business, Vetter describes itself as combining the agility of a private enterprise with the scale required to serve global clients, and emphasises commitments to quality, innovation, and sustainability alongside regional roots and social responsibility.
